Evidence map›Paper›PMID 38835350›Full record

ArticleCancer drug resistance (Alhambra, Calif.)2024

Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients.

Gabriele Perrone, Luigi Rigacci, Giandomenico Roviello, Ida Landini, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo, Monica Bocchia and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer drug resistance (Alhambra, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. OncoTargets and therapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gabriele PerroneDepartment of Health Sciences, University of Florence, Florence 50139, Italy.
Luigi RigacciResearch Unit of Hematology, Department of Medicine and Surgery, Campus Biomedico University, Rome 00128, Italy.
Giandomenico RovielloDepartment of Health Sciences, University of Florence, Florence 50139, Italy.
Ida LandiniDepartment of Health Sciences, University of Florence, Florence 50139, Italy.
Alberto FabbriUnit of Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena 53100, Italy.
Lorenzo IovinoUnit of Hematology, Santa Chiara University Hospital, University of Pisa, Pisa 56126, Italy.
Benedetta PucciniUnit of Hematology, Careggi University-Hospital, Florence 50134, Italy.
Emanuele CenciniUnit of Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena 53100, Italy.
Enrico OrciuoloUnit of Hematology, Santa Chiara University Hospital, University of Pisa, Pisa 56126, Italy.
Monica BocchiaUnit of Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena 53100, Italy.
Alberto BosiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Enrico MiniDepartment of Health Sciences, University of Florence, Florence 50139, Italy.
Stefania NobiliDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence 50139, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersDiffuse large B-cell lymphoma (DLBCL)host geneticsR-CHOP regimensingle nucleotide polymorphism (SNP)tumor drug resistance

Identifiers

PMID38835350
PMCPMC11149109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.